REVI Pilot Feasibility Trial in Long-Term Care
REVI
Intervention Program for Psychological Well-Being in Institutionalized Older Adults Through Virtual Reality
2 other identifiers
interventional
18
1 country
1
Brief Summary
This pilot study evaluates the feasibility, safety, and acceptability of an immersive virtual reality (VR) intervention designed to promote psychological well-being in older adults living in a long-term care facility. The study examines whether an eight-session VR program can be delivered safely and comfortably, whether participants tolerate and engage with the sessions, and whether the intervention shows preliminary signals of benefit in emotional well-being and subjective experience of presence. The results will inform the design and implementation of a larger, ongoing study using the same protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
July 1, 2026
2 months
July 28, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Recruitment Rate
Recruitment rate is defined as the proportion of eligible participants who enroll in the study during the recruitment period.
At the end of the recruitment period (March 13, 2026).
Retention Rate
Retention rate is defined as the proportion of enrolled participants who complete all scheduled assessments and sessions during the 4-week intervention period.
From enrollment through completion of the 4-week intervention period.
Adverse Events
Adverse events are monitored throughout the intervention period and recorded after each session, including discomfort, cybersickness, or any unexpected negative reactions.
From the first session through the final session of the 4-week intervention period.
Acceptability (NPT-ES)
Acceptability is assessed after each session using the adapted Non-Pharmacological Therapy Experience Scale (NPT-ES), which evaluates perceived usefulness, comfort, satisfaction, and willingness to continue the activity.
Immediately after each session during the 4-week intervention period.
Secondary Outcomes (3)
Psychological Well-Being (Ryff Scales)
From baseline assessment before starting the intervention through intermediate session assessments during the 4-week program and the post-intervention assessment at 4 weeks.
Sense of Presence (Presence Questionnaire)
Immediately after each immersion session during the 4-week intervention period.
Emotional Reactions (Session Questionnaire)
Immediately after each immersion session during the 4-week intervention period.
Study Arms (3)
Active IVR
EXPERIMENTALParticipants complete the full REVI protocol, consisting of eight individually guided immersive virtual reality sessions delivered twice weekly over four weeks. Sessions include structured interaction with immersive virtual environments, guided experiential tasks, and presence-enhancing activities aligned with the psychological well-being model.
Passive IVR
EXPERIMENTALParticipants complete eight immersive virtual reality sessions delivered twice weekly over four weeks. Sessions consist of passive exposure to immersive virtual environments without guided experiential tasks or structured interaction. Participants view the VR scenarios through Meta Quest 2 headsets while remaining seated and without engaging in presence-enhancing activities.
Control
NO INTERVENTIONParticipants do not receive any immersive virtual reality sessions. They complete the baseline and post-intervention assessments and join the study schedule at the same time points as the IVR groups to complete the inter-session evaluations appropriate for their condition. Participants receive usual care within the long-term care facility.
Interventions
Participants complete eight individually guided immersive virtual reality sessions delivered twice weekly over four weeks. Sessions include structured interaction with immersive virtual environments, guided experiential tasks, and presence-enhancing activities aligned with the psychological well-being model.
Participants complete eight immersive virtual reality sessions delivered twice weekly over four weeks. Sessions consist of passive exposure to immersive virtual environments without guided experiential tasks or structured interaction. Participants view the VR scenarios while remaining seated and without engaging in presence-enhancing activities.
Eligibility Criteria
You may qualify if:
- Residents of long-term care facilities.
- Age 65 years or older.
- Full functional independence (Barthel Index = 100).
- Adequate balance and gait to safely participate in VR sessions (Berg Balance Scale \> 45).
- Absence of significant cognitive impairment (MMSE ≥ 25 or CAMCOG-R ≥ 80).
- Absence of clinically significant depressive symptoms (GDS-SF ≤ 5).
- No prior experience with immersive virtual reality.
- Able to provide informed consent or have a legal representative who can do so.
- Able to remain seated for approximately 20 minutes per session.
- Willing to participate in eight VR sessions over four weeks.
You may not qualify if:
- Cognitive impairment that prevents understanding instructions or interacting with VR content.
- Balance or gait limitations judged by clinical staff to pose a safety risk during VR use.
- Medical or neurological conditions that contraindicate VR exposure (e.g., uncontrolled epilepsy, severe motion sickness).
- Acute medical instability or conditions requiring urgent clinical intervention.
- Any condition judged by clinical staff to pose a safety risk during VR immersion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Residencia San Juan de Dios
Seville, Spain
Related Publications (1)
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.
PMID: 15189396BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Only the investigator responsible for assigning participants to the three study groups was masked to participant identity during allocation. No other study personnel, participants, or outcome assessors were masked.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology, Principal Investigator
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start
March 16, 2026
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The sample size is small and the data collected include sensitive information from older adults residing in long-term care facilities, making full de-identification insufficient to ensure participant privacy. No repository or mechanism for IPD sharing is planned.